February 2023
WHO worried human-to-human transmission of bird flu cannot be ruled out
GENEVA— World Health Organization (WHO) experts have expressed their concern after two cases of humans catching H5N1 avian flu were confirmed this week. During a virtual press conference, WHO Director of Epidemic and Pandemic Preparedness and Prevention Sylvie Briand said the situation was “worrying.” The two cases were reported in Cambodia, where local authorities are […]
Hunger still blights the lives of Sudan’s children
KALMA (Sudan)— In Sudan’s sprawling Kalma camp for the displaced, Ansaf Omar lives with the gut-wrenching guilt of losing her toddler to a food crisis that has hit millions of people nationwide. “I am severely malnourished so I couldn’t breastfeed him,” said Ansaf, 34, a month after her one-and-half-year-old child died in Kalma camp just […]
RSF would not wage war against Sudanese army: second commander
Abdel Rahim Daglo Second Commander of the Rapid Support Forces (RSF) on Sunday ruled out the possibility of fighting between their forces and the Sudan Armed Forces (SAF). Recently, the Sudanese army’s top leaders repeated regular calls to integrate the paramilitary forces in the regular army as they are annoyed by his dissonant statements against […]
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FATE
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as […]
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Bioventus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BVS
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Bioventus Inc. (NASDAQ: BVS): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s February 11, 2021 initial public offering (the “IPO” or “Offering”); and/or (ii) between […]
BLRX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 6 Deadline in Securities Class Action Filed by the Firm – BLRX
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ: BLRX) between February 23, 2021 and September 19, 2022, both dates inclusive (the “Class Period”), of the important March 6, 2023 lead plaintiff deadline. SO WHAT: If you […]